Intestinal Fibrosis

Intestinal Fibrosis Model Using Intestinal Organoids

A pathological intestinal fibrosis model characterized by fibroblast activation and excessive extracellular matrix accumulation, resulting in tissue stiffening and structural deformation with activation of fibrosis-related signaling pathways.

This platform enables human-based in vitro evaluation of antifibrotic candidate compounds.

Challenges

Intestinal fibrosis is a major complication of chronic inflammatory bowel diseases, particularly Crohn’s disease. Progressive fibroblast activation and excessive extracellular matrix (ECM) deposition lead to tissue stiffening, luminal narrowing, and ultimately stricture formation.

Despite advances in anti-inflammatory biologics, effective antifibrotic therapies remain an unmet clinical need, partly due to the lack of predictive human-relevant preclinical models.

Discuss Your Intestinal Fibrosis Research

Our scientists will help design a human-relevant disease modeling study.

Intestinal Fibrosis Model

Our human intestinal organoid–based fibrosis model recapitulates key pathological hallmarks of intestinal fibrogenesis in vitro:

  • Sustained fibroblast activation and myofibroblast differentiation
  • Excessive collagen and ECM protein deposition
  • Measurable tissue stiffening and architectural distortion
  • Activation of canonical fibrosis signaling pathways (e.g., TGF-β–associated cascades)
By integrating epithelial organoids with stromal components, this platform reconstructs multicellular interactions that drive fibrotic remodeling in human intestine.

Related Solutions

Organoid Service
Organoid Service
Organoid Service
Organoid Service

Key Readouts

The model supports multi-layered characterization:

  • Immunofluorescence quantification of α-SMA and collagen I/III
  • Transcriptomic profiling of fibrosis-related genes
  • ECM remodeling and matrix composition analysis
  • Functional assessment of tissue stiffness
  • Drug-response profiling of antifibrotic candidates

Discuss Your Intestinal Fibrosis Research

Our scientists will help design a human-relevant disease modeling study.

Impact

Your CRO Partner for Human-Relevant Organoid Research & Drug Discovery

Human-relevant disease modeling services by Lambda Biologics